Delirium in the NICU (305)

Saturday, September 17, 2022

10:30 AM – 11:30 AM PDT

Location: Champagne 1-2

CE: 1

NCC Codes:
RNC-NIC: 2
NNP-BC: 2
RNC-LRN: 3
NCC Subspecialty Certifications:
C-ELBW (Code 7)
Pharmacology Credits: 0.25

Main Presenter(s)

Elizabeth W. McCutchon, EdD, MS, NNP-BC, PMHNP-BC

Neonatal Nurse Practitioner
Children's Hospital Colorado
Broomfield, Colorado, United States

Disclosure: I have no relevant financial relationship(s) with ineligible companies to disclose.

Slides Handouts

Moderator(s)

Brittany L. Kyle, RNC-NIC, C-ELBW, C-NNIC, C-ONQS, CBC

Clinical Nurse - Pediatrics
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States

Disclosure: Disclosure information not submitted.

Delirium occurs in approximately 25% to 50% of infants in the ICU. It can present as inconsolable agitation which is often treated with benzodiazepines. Yet benzodiazepines can worsen delirium. It is important to understand delirium so that we can first, try to prevent it and second, treat it appropriately.

Learning Objectives:

At the conclusion of this presentation, the learner will be able to:

Define delirium
Describe signs and symptoms of delirium in an infant
Explain risk factors for delirium
List delirium prevention strategies